Previous 10 | Next 10 |
The new joint venture will deploy up to $1.2 billion of additional capital to develop approximately 100 new CenterWell Senior Primary Care clinics between 2023 and 2025 and operate them to profitability. This joint venture expands upon an existing collaboration that is curre...
Jeffrey Smith's Starboard Value fund notable buy includes in LivePerson (LPSN) with 6.41M shares, Mercury Systems (MRCY) with 3.58M shares, Humana (HUM) with 0.97M and Kohl's (KSS), according to its 13F filing. Notable increased position includes in GoDaddyy (GDDY), Cyxtera (CYXT), Willis Tow...
Humana Specialty Pharmacy has won the MMIT Specialty Pharmacy Patient Choice Award in the PBM/Payer category for the fifth year in a row. The award recognizes best-in-class customer satisfaction and an unwavering commitment to patient care by a specialty pharmacy. “We...
Amid surging nursing expenses, some hospital chains are looking to introduce hefty increases to treatment costs that could lead to higher premiums for employers and workers, The Wall Street Journal reported on Sunday. HCA Healthcare Inc. (NYSE:HCA) and Universal Health Services...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Adding defensive healthcare stocks can be a great way to ride out continued volatility in the market. AbbVie ( ABBV ): Investors are overreacting to this venerable big pharma company’s recent earnings report...
Humana Inc. (NYSE: HUM) announced today that Susan M. Diamond, Chief Financial Officer, will make a presentation to investors at the BofA Securities Healthcare Conference on Tuesday, May 10, 2022 at 9:20 a.m. Pacific time. A live audio webcast of the presentation will be available v...
Humana Inc. (HUM) Q1 2022 Earnings Conference Call April 27, 2022 09:00 ET Company Participants Lisa Stoner - Vice President, Investor Relations Bruce Broussard - President and Chief Executive Officer Susan Diamond - Chief Financial Officer Joe Ventura - Chief Legal Officer Conference Call Pa...
Humana press release (NYSE:HUM): Q1 Non-GAAP EPS of $8.04 beats by $1.25. Revenue of $24.08B (+16.0% Y/Y) beats by $540M. 2022 Guidance: The company is pleased its strong start to the year has enabled it to raise its Adjusted EPS guidance for the year ending December 31, 2022 (FY22) by $...
Reports 1Q22 earnings per diluted common share of $7.29 on a GAAP basis, while reporting Adjusted EPS of $8.04 Updates FY 2022 EPS guidance to 'approximately $22.98' on a GAAP basis; raises to 'approximately $24.50' on an Adjusted basis, which continues to contemplate an expli...
Humana has been a great value creator over the past decade, driven by secular growth trends and sound operational performance. The company has been active on the dealmaking side, both as a buyer and seller, as neither action has a huge impact on the business. Right here, valuation...
News, Short Squeeze, Breakout and More Instantly...
New collaboration will allow Humana to further modernize its cloud infrastructure and leverage Google Cloud’s Generative AI capabilities to accelerate innovation in healthcare. Humana Inc. (NYSE: HUM), a leading health and well-being company, today announced a new multi-year agre...
Key investments with community partners expand options for historically unsupported populations Humana Healthy Horizons, the Medicaid business of leading health and well-being company Humana Inc. (NYSE: HUM), is investing in community-based organizations throughout Oklahoma to expan...
Lease agreement for new CenterWell Senior Primary Care and Conviva Care Centers locations will provide convenient primary care services designed especially for seniors. CenterWell, the health care services business of Humana Inc. (NYSE: HUM), today announced plans to lease clinical spac...